News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CeloNova BioSciences Release: New Treatment Option For Women An Alternative To Hysterectomy



3/11/2014 9:05:45 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN ANTONIO--(BUSINESS WIRE)--CeloNova BioSciences, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance expanding the indication for their leading Embozene® microsphere product to include the treatment of uterine fibroids. This approval will give women suffering from uterine fibroids an important treatment option performed by interventional radiologists called uterine fibroid embolization (UFE).

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES